January 25, 2019
JPMA President Joji Nakayama The Japan Pharmaceutical Manufacturers Association (JPMA) on January 24 issued its policy proposal for 2019, making unique propositions on drug pricing rules including the creation of a pricing premium for drugs carrying indications for pregnant women...read more